We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-5.85%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.2B
AUM Growth
-$3.94B
Cap. Flow
-$1.12B
Cap. Flow %
-3.19%
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$63.8M
2
ALGN icon
Align Technology
ALGN
+$61.4M
3
STLA icon
Stellantis
STLA
+$54.4M
4
UBS icon
UBS Group
UBS
+$49.7M
5
RSG icon
Republic Services
RSG
+$44M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$73.1M
2
IPGP icon
IPG Photonics
IPGP
+$62.1M
3
ADBE icon
Adobe
ADBE
+$61.1M
4
UNH icon
UnitedHealth
UNH
+$56.3M
5
AAPL icon
Apple
AAPL
+$54.5M

Sector Composition

Rank Sector Weight
1 Technology 29.78%
2 Healthcare 17.08%
3 Financials 11.22%
4 Consumer Discretionary 10.87%
5 Industrials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORLY icon
226
O'Reilly Automotive
ORLY
$75.1B
$36.7M 0.1%
802,710
+11,640
+1% +$520K
TTWO icon
227
Take-Two Interactive
TTWO
$46.1B
$36.6M 0.1%
238,129
-63,081
-21% -$10.1M
GLOB icon
228
Globant
GLOB
$1.65B
$36.5M 0.1%
139,230
-81,709
-37% -$20.7M
ALLY icon
229
Ally Financial
ALLY
$13.1B
$36.4M 0.1%
837,936
+253,518
+43% +$12M
EXAS
230
DELISTED
Exact Sciences
EXAS
$36.4M 0.1%
520,978
-52,401
-9% -$3.83M
MNST icon
231
Monster Beverage
MNST
$95.1B
$36.3M 0.1%
907,822
-30,260
-3% -$1.27M
ED icon
232
Consolidated Edison
ED
$41.4B
$35.8M 0.1%
378,559
+21,920
+6% +$1.89M
NSC icon
233
Norfolk Southern
NSC
$75.4B
$35.7M 0.1%
125,079
+2,529
+2% +$697K
A icon
234
Agilent Technologies
A
$39.6B
$35.7M 0.1%
269,485
+6,690
+3% +$921K
CINF icon
235
Cincinnati Financial
CINF
$27.8B
$35.6M 0.1%
261,925
-32,790
-11% -$4.03M
CCI icon
236
Crown Castle
CCI
$34.6B
$35.4M 0.1%
191,902
+14,223
+8% +$2.53M
INVH icon
237
Invitation Homes
INVH
$17.9B
$35.1M 0.1%
874,439
+80,900
+10% +$3.31M
IEX icon
238
IDEX
IEX
$17B
$34.8M 0.1%
181,383
+8,728
+5% +$1.77M
IQV icon
239
IQVIA
IQV
$40.7B
$34.7M 0.1%
150,064
-4,665
-3% -$1.1M
BG icon
240
Bunge Global
BG
$20.9B
$34.6M 0.1%
312,142
+307,542
+6,686% +$31.5M
HUM icon
241
Humana
HUM
$43.9B
$34.6M 0.1%
79,458
-20,673
-21% -$8.65M
ALNY icon
242
Alnylam Pharmaceuticals
ALNY
$38.3B
$33.9M 0.1%
207,896
-5,808
-3% -$885K
CHKP icon
243
Check Point Software Technologies
CHKP
$14.3B
$33.8M 0.1%
244,655
-7,467
-3% -$975K
BXP icon
244
Boston Properties
BXP
$11.6B
$33.8M 0.1%
262,599
+6,056
+2% +$734K
GRMN
245
Garmin
GRMN
$56.9B
$33.7M 0.1%
284,352
+21,700
+8% +$2.61M
BMRN icon
246
BioMarin Pharmaceuticals
BMRN
$11.9B
$33M 0.09%
428,607
-2,991
-0.7% -$250K
PRU icon
247
Prudential Financial
PRU
$42.6B
$32.8M 0.09%
277,930
-105,067
-27% -$11.9M
O icon
248
Realty Income
O
$61.1B
$32.8M 0.09%
473,692
+39,641
+9% +$2.69M
CYBR
249
DELISTED
CyberArk
CYBR
$32.5M 0.09%
192,720
+51,681
+37% +$7.84M
KR icon
250
Kroger
KR
$36.7B
$32.4M 0.09%
563,946
-894,673
-61% -$44.4M

Similar funds

Axa's Q1 2022 Portfolio in Review

As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Freshpet worth $30.3M.

  • Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
  • Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
  • Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
  • Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
  • Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
  • Axa opened 111 new positions and closed 94 in Q1 2022.
  • Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.